Physician profile
Herbert Wiser
NPI 1053573147
$1,472.36
in general payments reported to CMS, 2019-2025
19 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $92.27 · 2023: $434 · 2024: $482 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $202.14 | 2019 | |
| Teleflex LLC | $201.47 | 2023-2024 | Urolift |
| Olympus America INC. | $157.22 | 2023-2025 | Itind System |
| Edap Technomed INC | $144.00 | 2024 | |
| Progenics Pharmaceuticals, INC. | $115.21 | 2023 | Pylarify |
| Sumitomo Pharma America, INC. | $112.74 | 2023-2024 | Orgovyx, Gemtesa |
| Intuitive Surgical, INC. | $92.27 | 2020 | |
| Abbvie INC. | $82.34 | 2019-2024 | Botox, Lupron Depot |
| Astellas Pharma US INC | $58.69 | 2019-2024 | Myrbetriq, Xtandi |
| Endo Pharmaceuticals INC. | $55.75 | 2023-2024 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $55.14 | 2023-2024 | Jelmyto |
| Merck Sharp & Dohme LLC | $42.84 | 2024-2025 | Lynparza, Keytruda, Welireg |
| Laborie Medical Technologies Corp. | $35.01 | 2024 | Endosheath Technology, Kiwi Procup |
| Pfizer INC. | $23.28 | 2023 | |
| Coloplast Corp | $21.38 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20.79 | 2025 | Altaviva |
| Procept Biorobotics Corporation | $20.28 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.16 | 2023 | |
| Koelis INC. | $15.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Wiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.